Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 202

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

A Novel Cytoplasmic Protein with RNA-binding Motifs Is an Autoantigen in Human Hepatocellular Carcinoma

Open access
Zhang, Jian-Ying, Chan, Edward K.L., Peng, Xuan-Xian, Tan, Eng M.·1999·The Journal of Experimental Medicine

Abstract

In hepatocellular carcinoma (HCC), autoantibodies to intracellular antigens are detected in 30–40% of patients. Patients with chronic hepatitis or liver cirrhosis develop HCC, and when this occurs, some patients exhibit autoantibodies of new specificities. It has been suggested that these novel autoantibody responses may be immune system reactions to proteins involved in transformation-associated cellular events. One HCC serum shown to contain antibodies to unidentified cellular antigens was used to immunoscreen a cDNA expression library, and a full length cDNA clone was isolated with an open reading frame encoding 556 amino acids with a predicted molecular mass of 62 kD. The 62-kD protein contained two types of RNA-binding motifs, the consensus sequence RNA–binding domain (CS-RBD) and four hnRNP K homology (KH) domains. This protein, provisionally called p62, has close identity (66–70%) to three other proteins at the amino acid sequence level, and all four proteins may belong to a family having CS-RBD in the NH2-terminal region and four KH domains in the mid-to-COOH– terminal region. The homologous proteins are: KH domain–containing protein overexpressed in cancer (Koc); zipcode binding protein, a protein which binds to a conserved nucleotide element in chicken β-actin mRNA (ZBP1); and a protein which binds to a promoter cis element in Xenopus laevis TFIIIA gene (B3). p62 protein is cytoplasmic in location, and autoantibodies were found in 21% of a cohort of HCC patients. Patients with chronic hepatitis and liver cirrhosis, conditions which are frequent precursors to HCC, were negative for these autoantibodies, suggesting that the immune response might be related to cellular events leading to transformation. However, the possible involvement of p62 autoantigen as a factor in the transformation process remains to be elucidated.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.189.7.1101

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 43

  1. Tan, 1991, Autoantibodies in pathology and cell biology, Cell, 67, 841, 10.1016/0092-8674(91)90356-4 · DOI · Paper page
  2. Tan, 1997, Autoantibodies and autoimmunity: a three-decade perspective. A tribute to Henry G. Kunkel, Ann NY Acad Sci, 815, 1, 10.1111/j.1749-6632.1997.tb52040.x · DOI
  3. Miyachi, 1978, Autoantibody to a nuclear antigen in proliferating cells, J Immunol, 121, 2228, 10.4049/jimmunol.121.6.2228 · DOI · Paper page
  4. Bravo, 1987, Cyclin/PCNA is the auxiliary protein of DNA polymerase-δ, Nature, 326, 515, 10.1038/326515a0 · DOI · Paper page
  5. Chan, 1991, Human autoantibody to RNA polymerase I transcription factor hUBF. Molecular identity of nucleolus organizer region autoantigen NOR-90 and ribosomal RNA transcription upstream binding factor, J Exp Med, 174, 1239, 10.1084/jem.174.5.1239 · DOI
  6. Gottlieb, 1989, Function of the mammalian La protein: evidence for its action in transcription termination by RNA polymerase III, EMBO (Eur Mol Biol Organ) J, 8, 851, 10.1002/j.1460-2075.1989.tb03446.x · DOI · Paper page
  7. Reimer, 1987, Autoantibody to RNA polymerase I in scleroderma sera, J Clin Invest, 79, 65, 10.1172/JCI112809 · DOI · Paper page
  8. Lerner, 1979, Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus, Proc Natl Acad Sci USA, 76, 5495, 10.1073/pnas.76.11.5495 · DOI · Paper page
  9. Moroi, 1980, Autoantibody to centromere (kinetochore) in scleroderma sera, Proc Natl Acad Sci USA, 77, 1627, 10.1073/pnas.77.3.1627 · DOI · Paper page
  10. Brenner, 1981, Kinetochore structure, duplication, and distribution in mammalian cells: analysis by human autoantibodies from scleroderma patients, J Cell Biol, 91, 95, 10.1083/jcb.91.1.95 · DOI · Paper page
  11. Earnshaw, 1987, Molecular cloning of cDNA for CENP-B, the major human centromere, J Cell Biol, 104, 817, 10.1083/jcb.104.4.817 · DOI · Paper page
  12. Tan, 1988, Antinuclear antibodies (ANAs): Dignostically specific immune markers and clues toward the understanding of systemic autoimmunity, Clin Immunol Immunopathol, 47, 121, 10.1016/0090-1229(88)90066-9 · DOI · Paper page
  13. Tillman, 1992, Both IgM and IgG anti-DNA antibodies are the products of clonally selective B cell stimulation in (NZB × NZW)F1 mice, J Exp Med, 176, 761, 10.1084/jem.176.3.761 · doi:10.1084/jem.176.3.761
  14. Radic, 1994, Genetic and structural evidence for antigen selection of anti-DNA antibodies, Annu Rev Immunol, 12, 487, 10.1146/annurev.iy.12.040194.002415 · doi:10.1146/annurev.iy.12.040194.002415 · Paper page
  15. Burnham, 1972, Antinuclear antibodies in patients with malignancies, Lancet, 2, 2436
  16. Steiner, 1975, Antinuclear reactivity of sera in patients with leukemia and other neoplastic diseases, Clin Immunol Immunopathol, 4, 374, 10.1016/0090-1229(75)90006-9 · doi:10.1016/0090-1229(75)90006-9
  17. Thomas, 1983, Antinuclear, antinucleolar, and anticytoplasmic antibodies in patients with malignant melanoma, Cancer Res, 43, 1372
  18. Wasserman, 1975, Autoantibodies in patients with carcinoma of the breast: Correlation with prognosis, Clin Exp Immunol, 19, 417
  19. Pupa, 1993, Antibody response against the c-erbB-2 oncoprotein in breast carcinoma patients, Cancer Res, 53, 5864
  20. Dalmau, 1991, Anti-Hu associated paraneoplasic encephalomyelitis/ sensory neuropathy: a clinical study of 71 patients, Medicine, 71, 59, 10.1097/00005792-199203000-00001 · DOI · Paper page
  21. Buckanovich, 1997, The neuronal RNA binding protein Nova-1 recognizes specific RNA targets in vitro and in vivo, Mol Cell Biol, 17, 3194, 10.1128/MCB.17.6.3194 · DOI · Paper page
  22. Covini, 1997, Diversity of antinuclear antibody responses in hepatocellular carcinoma, J Hepatol, 26, 1255, 10.1016/S0168-8278(97)80460-6 · DOI
  23. Imai, 1992, Nucleolar antigens and autoantibodies in hepatocellular carcinoma and other malignancies, Am J Pathol, 140, 859
  24. Imai, 1993, Increasing titers and changing specificities of antinuclear antibodies in patients with chronic liver disease who develop hepatocellular carcinoma, Cancer, 71, 26, 10.1002/1097-0142(19930101)71:1<26::AID-CNCR2820710106>3.0.CO;2-N · DOI
  25. Imai, 1993, Novel nuclear autoantigen with splicing factor motifs identified with antibody from hepatocellular carcinoma, J Clin Invest, 92, 2419, 10.1172/JCI116848 · DOI
  26. Muro, 1995, A cell-cycle nuclear autoantigen containing WD-40 motifs expressed mainly in S and G2 phase cells, Biochem Biophys Res Commun, 207, 1029, 10.1006/bbrc.1995.1288 · DOI
  27. Winter, 1992, Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation, Cancer Res, 52, 4168
  28. Houghton, 1994, Cancer antigens: immune recognition of self and altered self, J Exp Med, 180, 1, 10.1084/jem.180.1.1 · DOI · Paper page
  29. Sahin, 1995, Human neoplasms elicit multiple specific immune responses in the autologous host, Proc Natl Acad Sci USA, 92, 11810, 10.1073/pnas.92.25.11810 · DOI · Paper page
  30. Old, 1998, New paths in human cancer serology, J Exp Med, 187, 1163, 10.1084/jem.187.8.1163 · DOI · Paper page
  31. Zhang, 1998, A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China, Int J Epidemiol, 27, 574, 10.1093/ije/27.4.574 · doi:10.1093/ije/27.4.574
  32. Covini, 1996, Comparison of protocols for depleting anti-E. coliantibody in immunoblotting of recombinant antigens, J Immunol Methods, 190, 143, 10.1016/0022-1759(95)00288-X · doi:10.1016/0022-1759(95)00288-x
  33. Devereux, 1984, A comprehensive set of sequence analysis programs for the VAX, Nucleic Acids Res, 12, 387, 10.1093/nar/12.1Part1.387 · DOI · Paper page
  34. Huang, 1994, On global sequence alignment, Comput Appl Biosci, 10, 227
  35. Pfeffer, 1995, Efficient one-tube RT-PCR amplification of rare transcripts using short sequence-specific reverse transcription primers, Biotechniques, 18, 204
  36. Burd, 1994, Conserved structures and diversity of functions of RNA-binding proteins, Science, 265, 615, 10.1126/science.8036511 · DOI · Paper page
  37. Muller-Pillasch, 1997, Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein, Oncogene, 14, 2729, 10.1038/sj.onc.1201110 · DOI · Paper page
  38. Ross, 1997, Characterization of a β-actin mRNA zipcode-binding protein, Mol Cell Biol, 17, 2158, 10.1128/MCB.17.4.2158 · DOI · Paper page
  39. Pfaff, 1992, Characterization of a Xenopus oocyte factor that binds to a developmentally regulated cis-element in the TFIIIA gene, Dev Biol, 151, 306, 10.1016/0012-1606(92)90235-9 · DOI
  40. Siomi, 1993, The pre-mRNA binding K protein contains a novel evolutionarily conserved motif, Nucleic Acids Res, 21, 1193, 10.1093/nar/21.5.1193 · DOI · Paper page
  41. Hahm, 1993, Isolation of a murine gene encoding a nucleic acid-binding protein with homology to hnRNP K, Nucleic Acids Res, 21, 3894, 10.1093/nar/21.16.3894 · doi:10.1093/nar/21.16.3894
  42. Davidoff, 1992, Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers, Proc Natl Acad Sci USA, 89, 3439, 10.1073/pnas.89.8.3439 · DOI · Paper page
  43. Chen, 1998, Identification of multiple cancer/ testis antigens by allogeneic antibody screening of a melanoma cell line library, Proc Natl Acad Sci USA, 95, 6919, 10.1073/pnas.95.12.6919 · doi:10.1073/pnas.95.12.6919

Cited by

See all 202

Metadata

Authors
Zhang, J.-Y., Chan, E. K. L., Peng, X.-X., & Tan, E. M.
Venue
The Journal of Experimental Medicine
Published
1999-04-05
Volume
189
Issue
7
Pages
1101-1110
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
OpenAlex
W2136902996
Cited by
202
References
1
FWCI
6.85
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Novel Cytoplasmic Protein with RNA-binding Motifs Is an Autoantigen in Human Hepatocellular Carcinoma. https://app.cochat.ai/papers/10.1084/jem.189.7.1101
The paper
Zhang, J.-Y., Chan, E. K. L., Peng, X.-X., & Tan, E. M. (1999). A Novel Cytoplasmic Protein with RNA-binding Motifs Is an Autoantigen in Human Hepatocellular Carcinoma. The Journal of Experimental Medicine. https://doi.org/10.1084/jem.189.7.1101

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.